New research indicates a potential link between certain blood pressure medications, particularly calcium channel blockers (CCBs), and an increased risk of glaucoma. Studies suggest that CCBs may contribute to glaucoma development by thinning retinal layers, rather than affecting intraocular pressure. This discovery prompts a reevaluation of treatment strategies for hypertensive patients, especially those with existing glaucoma or a predisposition to the condition.
Blood Pressure Drugs And Glaucoma Risk
Recent studies have highlighted a concerning association between the use of calcium channel blockers (CCBs) and an elevated risk of glaucoma. A large meta-analysis involving over 143,000 individuals found that patients on CCBs had a 23% higher likelihood of developing glaucoma. This risk nearly doubled for those using single-agent cardioselective CCBs. Another study, analyzing data from the UK Biobank, reported a 39% greater odds of glaucoma among CCB users.